Neonatal outcomes in preterm infants with severe congenital heart disease: a national cohort analysis
Neonatale Outcomes bei Frühgeborenen mit schwerer angeborener Herzkrankheit: nationale Kohortenanalyse
Frontiers in Pediatrics · 25.04.2024 · 12
DOI: 10.3389/fped.2024.1326804 ↗Auf einen Blick
Frühgeborene mit schwerer angeborener Herzkrankheit hatten häufiger neonatale Morbidität und eine höhere Mortalität als Frühgeborene ohne CHD. Das Risiko blieb in allen GA-Gruppen erhöht.
Fragestellung
Wie sind die neonatalen Outcomes von Frühgeborenen mit schwerer kongenitaler Herzkrankheit im Vergleich zu Frühgeborenen ohne CHD?
Methode
Analyse der National Inpatient Database mit ICD-10-Codes für Frühgeborene <37 Wochen mit schwerer CHD von 2016 bis 2020; Vergleich mit Frühgeborenen ohne CHD, adjustiert für GA, Geburtsgewicht und Geschlecht.
Ergebnisse
27.710 von 1.798.245 Frühgeborenen (1,5 %) hatten schwere CHD. Erhöhtes Risiko für NEC (OR 4,88; 95 %-KI 4,51–5,27), IVH (OR 6,22; 5,57–6,95), PVL (OR 3,21; 2,84–3,64) und BPD (OR 8,26; 7,50–10,06). Mortalität: 11,6 % vs. 2,5 %.
Schlussfolgerung der Autor:innen
Frühgeborene mit schwerer CHD haben ein hohes Risiko für neonatale Morbidität und Mortalität. Das erhöhte Risiko bestand in allen GA-Gruppen und CHD-Kategorien.
Kernaussagen
- NEC, IVH, PVL und BPD traten bei schwerer CHD häufiger auf
- Mortalität: 11,6 % mit CHD vs. 2,5 % ohne CHD
- Shunt-Läsionen hatten die höchste NEC-Rate und Mortalität
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pediatrics, online erschienen am 25.04.2024. Verfasst von Safwat Aly und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Boston Children's Hospital, Boston, MA, United States. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Neonatologie
Abstract (Originalsprache)
Background
Prematurity and congenital heart disease (CHD) are the leading causes of neonatal mortality and morbidity. Limited data are available about the outcomes of premature infants with severe CHD.
Methods
We queried The National Inpatient Database using ICD-10 codes for premature patients (<37 weeks) with severe CHD from 2016 to 2020. Severe CHDs were grouped into three categories: A. left-sided lesions with impaired systemic output, B. Cyanotic CHD, and C. Shunt lesions with pulmonary overcirculation. Patients with isolated atrial or ventricular septal defects and patent ductus arteriosus were excluded. We also excluded patients with chromosomal abnormalities and major congenital anomalies. Patients' demographics, clinical characteristics, and outcomes were evaluated by comparing premature infants with vs. without CHD adjusting for gestational age (GA), birth weight, and gender.
Results
A total of 27710 (1.5%) out of 1,798,245 premature infants had severe CHD. This included 27%, 58%, and 15% in groups A, B, and C respectively. The incidence of severe CHD was highest between 25 and 28 weeks of gestation and decreased significantly with increasing GA up to 36 weeks ( p < 0.001). Premature infants with severe CHD had a significantly higher incidence of neonatal morbidities including necrotizing enterocolitis (NEC) [OR = 4.88 (4.51–5.27)], interventricular hemorrhage [OR = 6.22 (5.57–6.95)], periventricular leukomalacia [OR = 3.21 (2.84–3.64)] and bronchopulmonary dysplasia [OR = 8.26 (7.50–10.06) compared to preterm infants of similar GA without CHD. Shunt lesions had the highest incidence of NEC (8.5%) compared to 5.3% in cyanotic CHD and 3.7% in left-sided lesions ( p < 0.001). Mortality was significantly higher in premature infants with CHD compared to control [11.6% vs. 2.5%, p < 0.001]. Shunt lesions had significantly higher mortality (11.0%) compared to those with left-sided lesions (8.3%) and cyanotic CHD (6.4%), p < 0.001.
Conclusion
Premature infants with severe CHD are at high risk of neonatal morbidity and mortality. Morbidity remains increased across all GA groups and in all CHD categories. This significant risk of adverse outcomes is important to acknowledge when managing this patient population and when counseling their families. Future research is needed to examine the impact of specific rather than categorized congenital heart defects on neonatal outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Boston Children's Hospital, Boston, MA, United States.
- Department of Pediatrics, Harvard Medical School, Boston, MA, United States.
- Department of Pediatrics, Nassau University Medical Center, East Meadow, NY, United States.
- Department of Neonatology, Cleveland Clinic, Cleveland, OH, United States.
Zitieren
APA
Aly, S., Qattea, I., Kattea, M. O., & Aly, H. Z. (2024). Neonatal outcomes in preterm infants with severe congenital heart disease: a national cohort analysis. Frontiers in Pediatrics, 12. https://doi.org/10.3389/fped.2024.1326804
Vancouver
Aly S, Qattea I, Kattea MO, Aly HZ. Neonatal outcomes in preterm infants with severe congenital heart disease: a national cohort analysis. Frontiers in Pediatrics. 2024;12. doi:10.3389/fped.2024.1326804
BibTeX
@article{Aly2024,
author = {Aly, Safwat and Qattea, Ibrahim and Kattea, Mohammad O and Aly, Hany Z},
title = {Neonatal outcomes in preterm infants with severe congenital heart disease: a national cohort analysis},
journal = {Frontiers in Pediatrics},
year = {2024},
volume = {12},
doi = {10.3389/fped.2024.1326804}
}
EUVIMED